Impact Of Respiratory Diseases Growth On The Market Is Supporting Development Across The Budesonide Market

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Is The Forecasted Rise In Market Size Of The Budesonide Market During The Forecast Period?

The budesonide market size has experienced robust expansion in recent years. Looking ahead, the market is projected to expand from $10.26 billion in 2025 to $10.88 billion in 2026, registering a compound annual growth rate (CAGR) of 6.0%. Historically, this growth can be linked to factors such as the increasing prevalence of asthma and copd, the widespread adoption of corticosteroid treatments, the development of inhalation therapies, a rise in ibd diagnosis, and advancements in drug delivery technologies.

The budesonide market is anticipated to show robust expansion over the next few years. It is projected to reach $13.72 billion in 2030, growing at a compound annual growth rate (CAGR) of 6.0%. This anticipated growth during the forecast period is driven by factors such as an aging population, an increase in chronic inflammatory diseases, the expansion of generic drug usage, the development of home-based therapies, and a rising burden of respiratory illnesses. Significant trends expected in this period include the increased application of inhaled corticosteroids in chronic respiratory care, a greater adoption in inflammatory bowel disease management, a growing preference for targeted localized steroid therapy, the broader availability of generic budesonide formulations, and an enhanced use in long-term maintenance therapy.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21121&type=smp

Which Significant Factors Are Encouraging Growth In The Budesonide Market?

The growing prevalence of respiratory ailments is anticipated to boost the expansion of the budesonide market in the future. These conditions involve medical disorders impacting the organs and tissues responsible for gas exchange in air-breathing organisms. The rise in such diseases stems from escalating air pollution, especially exposure to particulate matter and allergens, significantly influencing the incidence of asthma and chronic obstructive lung disease. Budesonide finds application in respiratory conditions like asthma and chronic obstructive pulmonary disease (COPD) to alleviate inflammation, enhance airflow, and avert symptoms such as wheezing and shortness of breath. For example, in August 2025, the Centers for Disease Control and Prevention, a Switzerland-based public health agency, reported that 90% of the nation’s 4.9 trillion dollars in annual health care spending is linked to individuals with chronic and mental health conditions, with over 84,000 Americans dying annually from heart disease or stroke, and cardiovascular disease costs are forecast to reach approximately 2 trillion dollars by 2050. Consequently, the increasing prevalence of respiratory diseases is set to stimulate the growth of the budesonide market.

How Is The Budesonide Market Examined Through Segment Analysis?

The budesonide market covered in this report is segmented –

1) By Type: Inhalation Powder, Aerosols, Tablets And Capsules

2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

3) By Application: Nose Disease Treatment, Inflammatory Bowel Disease Treatment, Respiratory Disease Treatment, Other Applications

Subsegments:

1) By Inhalation Powder: Dry Powder Inhalers (DPI), Soft Mist Inhalers (SMI)

2) By Aerosols: Metered-Dose Inhalers (MDI), Breath-Activated Inhalers

3) By Tablets And Capsules: Oral Tablets, Oral Capsules

Which Trends Are Contributing To Changes In The Budesonide Market?

Leading companies within the budesonide market are prioritizing innovations in respiratory care, specifically oral therapies, to boost patient comfort, ensure better adherence to treatment, and broaden the available therapies for asthma and other respiratory ailments. Budesonide oral therapy is a form of budesonide administered orally, predominantly employed for addressing inflammatory disorders. As an illustration, in February 2024, Takeda Pharmaceuticals, a Japan-based pharmaceutical firm, declared that the Food and Drug Administration (FDA), a US federal agency, had given its approval for EOHILIA, an oral suspension of budesonide, making it the first and sole FDA-cleared oral treatment for individuals aged 11 and older suffering from eosinophilic esophagitis (EoE). Moreover, the FDA’s authorization of EOHILIA 2 mg twice daily was granted following an assessment of efficacy and safety data obtained from two multicenter, randomized, double-blind, parallel-group, placebo-controlled 12-week studies involving patients aged 11 to 56 diagnosed with EoE.

Who Are The Key Market Participants In The Budesonide Market?

Major companies operating in the budesonide market are AstraZeneca AB, Novartis AG, Takeda Pharmaceuticals Company Limited, Viatris Inc., Teva Pharmaceutical Industries Ltd., Sandoz AG, Aurobindo Pharma Limited, Chiesi Farmaceutici S.p.A., Cipla Limited, Lupin Limited, Orion Corporation, Salix Pharmaceuticals Inc., Synmosa Biopharma Corporation, Cosmo Pharmaceuticals N.V., Skyepharma Holdings Inc., Manus Aktteva Biopharma LLP, Cennet Biopharma Private Limited, Santarus Inc., SiNi Pharma Private Limited, Shanghai Sine Promod Pharmaceutical Co. Ltd.

Access The Complete Budesonide Market Report:

https://www.thebusinessresearchcompany.com/report/budesonide-global-market-report

Which Region Stands As The Largest Contributor To The Budesonide Market?

North America was the largest region in the budesonide market in 2025. The regions covered in the budesonide market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Budesonide Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=21121&type=smp

Browse Through More Reports Similar to the Global Budesonide Market 2026, By The Business Research Company

Cannabis Capsule Market Report 2026

https://www.thebusinessresearchcompany.com/report/cannabis-capsule-global-market-report

Tea Capsule Market Report 2026

https://www.thebusinessresearchcompany.com/report/tea-capsule-global-market-report

Cannabis Extract Market Report 2026

https://www.thebusinessresearchcompany.com/report/cannabis-extract-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795